Anticancer Therapeutics: From Drug Discovery to Clinical Applications
- ISBN-10
- 1118696204
- ISBN-13
- 9781118696200
- Series
- Anticancer Therapeutics
- Category
- Science
- Pages
- 448
- Language
- English
- Published
- 2017-12-11
- Publisher
- John Wiley & Sons
- Authors
- Paul W. Groundwater, Adam Todd, Jason H. Gill
Description
An integrated presentation of the basic science and clinical applications of anticancer agents Aimed at both undergraduate and postgraduate readers, this unique text provides readers with a fully-integrated presentation of all aspects of the science of anticancer drugs, including their chemistry, pharmacology, and clinical applications. After heart disease, cancer is the number one killer worldwide, and the tumor microenvironment is forever changing, creating an ever-greater demand for safer, more effective anticancer agents. In response to that demand, the $100 billion cancer drug market continues to grow, with our increased understanding of cancer leading to new drugs being used clinically almost every year. Anticancer Therapeutics is divided into three sections. Section 1 is an introduction to cancer and therapeutics, and covers the etiology and cellular and molecular basis of cancer. In Section 2, the authors focus on the anticancer agents — their discovery, synthesis, mode of action, mechanisms of resistance, and adverse reactions. Section 3 focuses on specific cancers, explaining how and why the various agents discussed in Section 2 are used, both individually and in combination, to treat different cancers. Integrates aspects of basic science, including chemistry and pharmacology and clinical medicine in relation to cancer therapeutics Written by an author team comprising specialists in medicinal chemistry, pharmacology, and oncology Features full-color images throughout illustrating how drugs bind to cellular targets and exert their pharmacological effect Divided into three sections, covering the etiology and cellular and molecular basis of cancer, anticancer agents, and drug applications for different cancers. Providing the reader with an integrated understanding of all aspects of the science of anticancer agents, this is an ideal textbook for undergraduates studying medicine, nursing, medicinal chemistry, pharmacy, pharmacology and other allied heath / life sciences. It is also a valuable bench reference for pharmacists, medics, and pharmaceutical researchers working in both academia and industry.
Get the book
Other editions
-
- 2018-02-20
- 448 pages
- Paperback
- John Wiley & Sons
-
- 2017-12-08
- 448 pages
- Ebook
- John Wiley & Sons
-
- 2018-01-29
- 326 pages
- Paperback
- Wiley
Similar books
-
Macromolecular Anticancer Therapeutics
By Patrick Couvreur, L. Harivardhan ReddyThis book is unique and assembles various types and aspects of macromolecular anticancer therapeutics for cancer therapy in one shell and conveys the importance of this interdisciplinary field to the broad audience.
-
Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics
By Prashant Kesharwani, Kishore M. Paknikar, Virendra GajbhiyeS. Movassaghian, V.P. Torchilin, Long-circulating therapies for cancer treatment, in: Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies, Elsevier, 2015, pp. 433e462. M. Oishi, K. Kataoka, Y. Nagasaki, ...
-
RNA Delivery Function for Anticancer Therapeutics
By Loutfy H. MadkourThis book presents an overview of the current status of translating the RNAi cancer therapeutics in the clinic, a brief description of the biological barriers in drug delivery, and the roles of imaging in aspects of administration route, ...
-
Neurological Adverse Reactions to Anticancer Drugs
By Jerzy HildebrandIndispensable to the neuro-oncologist and useful to all physicians managing cancer patients, this book is a valuable source of current information.
-
Medicinal Chemistry of Anticancer Drugs
By Carmen Avendano, J. Carlos MenendezAppels MMGM, Bolijn MJ, Chan K, Stephens TC, Hoctin-Boes G, et al. Br J Cancer 2008;98:1951. Reid TS, Beese LS. Biochemistry 2004:43:6877. Reid TS, Long SB, Beese LS. Biochemistry 2004:43:9000. Caponigro F, Casale M, Bryce J. Expert ...
-
Assessing the Economic Value of Anticancer Therapies
By Niels NeymarkThis is also true for cancer, despite the aura of sanctity often of surrounding this dreaded disease and the apparent willingness the general population to spend large sums in this area and do "everything possible" for the patients.
-
The Search for New Anticancer Drugs
By Michael Waring, B.A. PonderThis book represents a compilation of views and progress reports which illustrate the diversity of approaches to the problem. Recent research has confirmed the belief that critical genetic changes are at work in cancer cells.
-
Anticancer Drugs
By Niamh M O’Boyle, Mary J MeeganIn this Special Issue of Pharmaceuticals, we highlight the opportunities and challenges in the discovery and design of innovative cancer therapies, novel small-molecule cancer drugs and antibody–drug conjugates, with articles covering a ...
-
Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer...
By Miles Hacker, John S. Lazo, Thomas R. TrittonBecause of this, the unpredicted toxicities are referred to as dose limiting. They represent a significant barrier to the ultimate efficacy of several of our most important anticancer drugs.
-
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval
By Beverly A. TeicherThe fee code for users of the Transactional Reporting Service is: [0-89603-460-7/97 $8.00 + $00.25]. Library of Congress Cataloging-in-Publication Data Anticancer drug development guide: preclinical screening, clinical trials, ...